{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,3]],"date-time":"2026-07-03T07:28:20Z","timestamp":1783063700541,"version":"3.54.6"},"reference-count":16,"publisher":"e-Century Publishing Corporation","issue":"3","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Int J Physiol Pathophysiol Pharmacol"],"DOI":"10.62347\/zbrq1229","type":"journal-article","created":{"date-parts":[[2025,7,7]],"date-time":"2025-07-07T04:49:01Z","timestamp":1751863741000},"page":"94-98","source":"Crossref","is-referenced-by-count":1,"title":["Diagnostic challenges in cardiac amyloidosis: a case report of negative initial endomyocardial biopsy"],"prefix":"10.62347","volume":"17","author":[{"given":"Azad","family":"Mojahedi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"48694","published-online":{"date-parts":[[2025]]},"reference":[{"key":"ref0","doi-asserted-by":"publisher","unstructured":"Martinez-Naharro A, Hawkins PN and Fontana M. Cardiac amyloidosis. Clin Med (Lond) 2018; 18 Suppl 2: s30-s35.","DOI":"10.7861\/clinmedicine.18-2-s30"},{"key":"ref1","doi-asserted-by":"publisher","first-page":"525","DOI":"10.1007\/s12471-019-1299-1","article-title":"Cardiac amyloidosis: the need for early diagnosis","volume":"27","author":"MIFJ","year":"2019","unstructured":"Oerlemans MIFJ, Rutten KHG, Minnema MC, Raymakers RAP, Asselbergs FW and de Jonge N. Cardiac amyloidosis: the need for early diagnosis. Neth Heart J 2019; 27: 525-536.","journal-title":"Neth Heart J"},{"key":"ref2","doi-asserted-by":"publisher","unstructured":"Kittleson MM, Maurer MS, Ambardekar AV, Bullock-Palmer RP, Chang PP, Eisen HJ, Nair AP, Nativi-Nicolau J and Ruberg FL; American Heart Association Heart Failure and Transplantation Committee of the Council on Clinical Cardiology. Cardiac amyloidosis: evolving diagnosis and management: a scientific statement from the American Heart Association. Circulation 2020; 142: e7-e22.","DOI":"10.1161\/CIR.0000000000000792"},{"key":"ref3","doi-asserted-by":"publisher","unstructured":"Musetti V, Greco F, Aimo A, Castiglione V, Vergaro G, Panichella G, Limongelli G, Merlo M, Emdin M and Pucci A. Cardiac amyloidosis: role of the endomyocardial biopsy. Heart Fail Clin 2024; 20: e23-e31.","DOI":"10.1016\/j.hfc.2024.09.007"},{"key":"ref4","doi-asserted-by":"publisher","unstructured":"Ashraf I, Peck MM, Maram R, Mohamed A, Ochoa Crespo D, Kaur G and Malik BH. Association of arrhythmias in cardiac amyloidosis and cardiac sarcoidosis. Cureus 2020; 12: e9842.","DOI":"10.7759\/cureus.9842"},{"key":"ref5","doi-asserted-by":"publisher","first-page":"624","DOI":"10.1161\/CIRCULATIONAHA.114.011522","article-title":"Cardiac sarcoidosis: epidemiology, characteristics, and outcome over 25 years in a nationwide study","volume":"131","author":"Kandolin","year":"2015","unstructured":"Kandolin R, Lehtonen J, Airaksinen J, Vihinen T, Miettinen H, Ylitalo K, Kaikkonen K, Tuohinen S, Haataja P, Kerola T, Kokkonen J, Pelkonen M, Pietilä-Effati P, Utrianen S and Kupari M. Cardiac sarcoidosis: epidemiology, characteristics, and outcome over 25 years in a nationwide study. Circulation 2015; 131: 624-632.","journal-title":"Circulation"},{"key":"ref6","doi-asserted-by":"publisher","first-page":"3054","DOI":"10.3390\/biomedicines10123054","article-title":"Tissue characterization in cardiac amyloidosis","volume":"10","author":"Musetti","year":"2022","unstructured":"Musetti V, Greco F, Castiglione V, Aimo A, Palmieri C, Genovesi D, Giorgetti A, Emdin M, Vergaro G, McDonnell LA and Pucci A. Tissue characterization in cardiac amyloidosis. Biomedicines 2022; 10: 3054.","journal-title":"Biomedicines"},{"key":"ref7","doi-asserted-by":"publisher","first-page":"312","DOI":"10.1159\/000508022","article-title":"Confirming the diagnosis of amyloidosis","volume":"143","author":"Wisniowski","year":"2020","unstructured":"Wisniowski B and Wechalekar A. Confirming the diagnosis of amyloidosis. Acta Haematol 2020; 143: 312-321.","journal-title":"Acta Haematol"},{"key":"ref8","doi-asserted-by":"publisher","first-page":"1554","DOI":"10.1093\/eurheartj\/ehab072","article-title":"Diagnosis and treatment of cardiac amyloidosis: a position statement of the ESC Working Group on Myocardial and Pericardial Diseases","volume":"42","author":"Garcia-Pavia","year":"2021","unstructured":"Garcia-Pavia P, Rapezzi C, Adler Y, Arad M, Basso C, Brucato A, Burazor I, Caforio ALP, Damy T, Eriksson U, Fontana M, Gillmore JD, Gonzalez-Lopez E, Grogan M, Heymans S, Imazio M, Kindermann I, Kristen AV, Maurer MS, Merlini G, Pantazis A, Pankuweit S, Rigopoulos AG and Linhart A. Diagnosis and treatment of cardiac amyloidosis: a position statement of the ESC Working Group on Myocardial and Pericardial Diseases. Eur Heart J 2021; 42: 1554-1568.","journal-title":"Eur Heart J"},{"key":"ref9","doi-asserted-by":"publisher","first-page":"100","DOI":"10.1016\/j.amjcard.2024.05.007","article-title":"Pericardial disease in cardiac amyloidosis: a comprehensive review","volume":"223","author":"Badwan","year":"2024","unstructured":"Badwan O, Berglund F, Rosenzveig A, Persits I, Gharaibeh A, Kumar A, Agrawal A, Sul L, Chan N, Wang TKM, Hanna M and Klein AL. Pericardial disease in cardiac amyloidosis: a comprehensive review. Am J Cardiol 2024; 223: 100-108.","journal-title":"Am J Cardiol"},{"key":"ref10","doi-asserted-by":"publisher","first-page":"51","DOI":"10.62347\/QHVI3317","article-title":"Advances in nanotechnology for targeted drug delivery in neurodegenerative diseases","volume":"14","author":"Rafieezadeh","year":"2025","unstructured":"Rafieezadeh D, Sabeti G, Khalaji A and Mohammadi H. Advances in nanotechnology for targeted drug delivery in neurodegenerative diseases. Am J Neurodegener Dis 2025; 14: 51-57.","journal-title":"Am J Neurodegener Dis"},{"key":"ref11","doi-asserted-by":"publisher","first-page":"107","DOI":"10.62347\/HFPU3214","article-title":"Safety and effectiveness of micropigmentation skin grafting using the Meek method","volume":"14","author":"Rafieezadeh","year":"2024","unstructured":"Rafieezadeh D and Abbaspour M. Safety and effectiveness of micropigmentation skin grafting using the Meek method. Int J Burns Trauma 2024; 14: 107-114.","journal-title":"Int J Burns Trauma"},{"key":"ref12","doi-asserted-by":"publisher","first-page":"118","DOI":"10.62347\/TUVQ7468","article-title":"Marine bioactive peptides with anticancer potential, a narrative review","volume":"15","author":"Rafieezadeh","year":"2024","unstructured":"Rafieezadeh D and Esfandyari G. Marine bioactive peptides with anticancer potential, a narrative review. Int J Biochem Mol Biol 2024; 15: 118-126.","journal-title":"Int J Biochem Mol Biol"},{"key":"ref13","doi-asserted-by":"publisher","first-page":"742","DOI":"10.1007\/s00508-020-01781-z","article-title":"Diagnosis and treatment of cardiac amyloidosis: an interdisciplinary consensus statement","volume":"132","author":"Bonderman","year":"2020","unstructured":"Bonderman D, Pölzl G, Ablasser K, Agis H, Aschauer S, Auer-Grumbach M, Binder C, Dörler J, Duca F, Ebner C, Hacker M, Kain R, Kammerlander A, Koschutnik M, Kroiss AS, Mayr A, Nitsche C, Rainer PP, Reiter-Malmqvist S, Schneider M, Schwarz R, Verheyen N, Weber T, Zaruba MM, Badr Eslam R, Hülsmann M and Mascherbauer J. Diagnosis and treatment of cardiac amyloidosis: an interdisciplinary consensus statement. Wien Klin Wochenschr 2020; 132: 742-761.","journal-title":"Wien Klin Wochenschr"},{"key":"ref14","doi-asserted-by":"publisher","first-page":"81","DOI":"10.62347\/AUPQ6330","article-title":"Extracellular vesicles and their therapeutic applications: a review article (part 2)","volume":"16","author":"Rafieezadeh","year":"2024","unstructured":"Rafieezadeh D. Extracellular vesicles and their therapeutic applications: a review article (part 2). Int J Physiol Pathophysiol Pharmacol 2024; 16: 81-88.","journal-title":"Int J Physiol Pathophysiol Pharmacol"},{"key":"ref15","doi-asserted-by":"publisher","first-page":"1591","DOI":"10.1161\/CIRCULATIONAHA.120.048323","article-title":"Uncommon disease in a rare location: the mystery of the rapidly progressive cardiomyopathy","volume":"142","author":"Ajufo","year":"2020","unstructured":"Ajufo E, Kansagra A, Torrealba J and Grodin JL. Uncommon disease in a rare location: the mystery of the rapidly progressive cardiomyopathy. Circulation 2020; 142: 1591-1595.","journal-title":"Circulation"}],"container-title":["International Journal of Physiology, Pathophysiology and Pharmacology"],"original-title":[],"link":[{"URL":"https:\/\/e-century.us\/files\/ijppp\/17\/3\/ijppp0164514.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,18]],"date-time":"2025-12-18T01:50:32Z","timestamp":1766022632000},"score":1,"resource":{"primary":{"URL":"https:\/\/e-century.us\/files\/ijppp\/17\/3\/ijppp0164514.pdf"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025]]},"references-count":16,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2025]]}},"URL":"https:\/\/doi.org\/10.62347\/zbrq1229","relation":{},"ISSN":["1944-8171"],"issn-type":[{"value":"1944-8171","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025]]}}}